J0750 Insurance Policy Changes

HCPCS J0750 is officially defined as "Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)." HCPCS J0750 is referenced in 4 tracked payer policy changes from Health Net and Arkansas Blue Cross Blue Shield. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J0750 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.